A. Tanatar Et Al. , "Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.," Expert opinion on biological therapy , vol.23, no.3, pp.305-313, 2023
Tanatar, A. Et Al. 2023. Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.. Expert opinion on biological therapy , vol.23, no.3 , 305-313.
Tanatar, A., Akgün, Ö., Çağlayan, Ş., Bağlan, E., Otar Yener, G., Öztürk, K., ... Çakan, M.(2023). Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.. Expert opinion on biological therapy , vol.23, no.3, 305-313.
Tanatar, Ayşe Et Al. "Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.," Expert opinion on biological therapy , vol.23, no.3, 305-313, 2023
Tanatar, Ayşe Et Al. "Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.." Expert opinion on biological therapy , vol.23, no.3, pp.305-313, 2023
Tanatar, A. Et Al. (2023) . "Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.." Expert opinion on biological therapy , vol.23, no.3, pp.305-313.
@article{article, author={Ayşe Tanatar Et Al. }, title={Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.}, journal={Expert opinion on biological therapy}, year=2023, pages={305-313} }